Sema4

📍 Stamford, United States🗓 Founded 2017👥 269 employees💰 Last funded Jul 2021
Biotechnology Research🌐 bit.ly
Website LinkedIn
Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Centrellis®, our innovative health intelligence platform, is enabling us to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all. In addition to LinkedIn, stay connected with us via the following social media channels: - Twitter: https://twitter.com/sema4 - Facebook: https://www.facebook.com/Sema4/ - Instagram: https://www.instagram.com/sema4/
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Sema4?
Sema4 has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Sema4 last raise funding?
The most recent investment in Sema4 recorded on gritt.io was in July 2021.
When was Sema4 founded?
Sema4 was founded in 2017.
What industry is Sema4 in?
Sema4 operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Sema4 based?
Sema4 is headquartered in Stamford, United States.